Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$5.2 - $8.77 $3.46 Million - $5.83 Million
-665,304 Closed
0 $0
Q2 2023

Aug 14, 2024

BUY
$5.86 - $7.93 $3.13 Million - $4.23 Million
533,791 New
533,791 $3.21 Million
Q2 2023

Aug 14, 2023

SELL
$5.86 - $7.93 $3.72 Million - $5.04 Million
-635,156 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$5.85 - $9.84 $3.35 Million - $5.64 Million
572,904 New
572,904 $3.55 Million
Q4 2022

Feb 14, 2023

BUY
$6.88 - $9.55 $3.94 Million - $5.47 Million
572,904 New
572,904 $5.29 Million
Q3 2022

Nov 13, 2023

BUY
$8.19 - $13.2 $5.45 Million - $8.78 Million
665,304 New
665,304 $6.29 Million
Q2 2022

Aug 14, 2023

BUY
$7.65 - $14.24 $4.86 Million - $9.04 Million
635,156 New
635,156 $6.45 Million
Q1 2022

May 12, 2023

SELL
$13.02 - $20.78 $611,262 - $975,579
-46,948 Reduced 8.19%
525,956 $7.49 Million
Q1 2022

May 09, 2022

SELL
$13.02 - $20.78 $2.27 Million - $3.62 Million
-174,037 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$19.35 - $25.54 $3.37 Million - $4.44 Million
174,037 New
174,037 $3.59 Million
Q3 2021

Nov 14, 2022

BUY
$21.65 - $39.49 $2.4 Million - $4.37 Million
110,649 New
110,649 $2.53 Million
Q3 2021

Nov 05, 2021

SELL
$21.65 - $39.49 $4.87 Million - $8.88 Million
-224,973 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$15.5 - $22.48 $3.49 Million - $5.06 Million
224,973 New
224,973 $4.69 Million
Q2 2021

Aug 10, 2021

SELL
$15.5 - $22.48 $3.22 Million - $4.68 Million
-207,994 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$14.84 - $22.23 $3.09 Million - $4.62 Million
207,994 New
207,994 $4.19 Million
Q1 2021

May 07, 2021

SELL
$14.84 - $22.23 $6.19 Million - $9.28 Million
-417,354 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$9.4 - $16.7 $3.92 Million - $6.97 Million
417,354 New
417,354 $6.32 Million
Q4 2020

Feb 10, 2021

SELL
$9.4 - $16.7 $5.73 Million - $10.2 Million
-609,128 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$10.54 - $24.96 $6.42 Million - $15.2 Million
609,128 New
609,128 $6.42 Million
Q2 2019

Aug 09, 2019

SELL
$16.26 - $26.42 $1.3 Million - $2.11 Million
-80,000 Closed
0 $0
Q1 2019

May 11, 2020

BUY
$15.97 - $22.5 $1.28 Million - $1.8 Million
80,000 New
80,000 $1.5 Million

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $159M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.